Tuesday, October 25, 2022
12:00PM – 1:00PM ET
Please note this TeleECHO program is 12:00PM Eastern, 11:00AM Central, 10:00AM Mountain and 9:00AM Pacific.
PROGRAM OVERVIEW
This activity was designed to help oncologists and the multidisciplinary care team personalize gastric cancer treatment based on biomarker testing and use targeted therapies for HER2 positive disease treatment beyond the first line.
FACULTY PRESENTER
Richard Dunne, MD
Assistant Professor of Medicine
Wilmot Cancer Institute
University of Rochester Medical Center
Rochester, NY
TARGET AUDIENCE
This activity is designed to meet the educational needs of community medical oncologists, internal medicine physicians, primary care physicians, pathologists and others (eg, nurse practitioners, pharmacists, physician assistants, oncology nurses) involved in the management of patients with gastric and gastroesophageal junction cancers.
EDUCATIONAL OBJECTIVES
Upon completing this program, attendees should be able to:
- Review recent ADC trials results in the second-line treatment of HER2-positive, gastric and gastroesophageal junction cancers
- Summarize the signs, symptoms, and interventions of anti-HER2 targeted therapies in the treatment of patients with GC or GEJ malignancies
- Explain the application of practice guidelines in the management of patients with HER2-positive GC or GEJ who have progressed beyond the first-line
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live virtual activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live virtual activity.
NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses involved in the care of patients with gastric and gastroesophageal junction cancers.
CNE Credits: 1.0 ANCC Contact Hour.
CNE ACCREDITATION STATEMENT
Ultimate Medical Academy/Complete Conference Management (CCM) is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
